Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 have?
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 has 72 citations in the OpenAlex counts ScholarIQ stores.
When was Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 published?
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 has 2022 year in the ScholarIQ index.
What is the open-access status of Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19?
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 has gold oa status in the ScholarIQ index.
What is the DOI of Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19?
The DOI for Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 is on the source record.
What is the PMID of Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19?
The PMID for Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 is on the source record.
What is the OpenAlex record for Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19?
The OpenAlex for Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 is on the source record.